iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors
Yahoo Finance · May 8, 2026 · iBio, Inc. Common Stock (IBIO)
SAN DIEGO, May 08, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases announced today the appointment of Elizabeth Stoner, M.D., M.S. to its Board of Directors. Dr. Stoner is appointed as an independent member of the Board of Directors and as a member of the Compensation Committee, following the transition of Eef Schimmelpennink from this position, who has stepped down from the Board. “We are ex
Not investment advice. Cached headline, not a full reprint.